Neuvivo Launches to Develop and Market Effective and Safe Treatments for ALS

PALO ALTO, Calif.: PALO ALTO, Calif., Dec. 1, 2021 /PRNewswire/ -- Neuvivo, Inc., a company developing clinical-stage treatments for ALS and other neurodegenerative diseases, today announced its corporate launch, the expansion of its executive team and the creation of its Scientific Advisory Board. Neuvivo's lead candidate, NP001, has received Orphan...

Click to view original post